Ieq Capital, LLC Prometheus Biosciences, Inc. Transaction History

Ieq Capital, LLC

  • $8.04 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$36.06 - $117.21 $196,382 - $638,325
-5,446 Reduced 35.26%
10,000 $1.1 Million
Q3 2022

Nov 03, 2022
BUY
$28.17 - $59.01 $153,413 - $321,368
5,446 Added 54.46%
15,446 $911,000
Q4 2021

Jan 31, 2022
BUY
$22.28 - $39.54 $222,800 - $395,400
10,000 New
10,000 $395,000

Others Institutions Holding RXDX

# of Institutions
2
Shares Held
29.6K
Call Options Held
0
Put Options Held
0
View Full List

About Prometheus Biosciences, Inc.

RXDX Quotes by TradingView
  • Ticker RXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,904,100
  • Description
  • Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...
More about RXDX
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email